The use of upconverting phosphors in point-of-care (POC) testing

Hans J. Tanke; Michel Zuiderwijk; Karien C. Wiesmeijer; Robert N. Breedveld; William R. Abrams; Claudia J. de Dood; Elisa M. Tjon Kon Fat; Paul L. A. M. Corstjens

doi:10.1117/12.2036906

4 March 2014 The use of upconverting phosphors in point-of-care (POC) testing

Hans J. Tanke, Michel Zuiderwijk, Karien C. Wiesmeijer, Robert N. Breedveld, William R. Abrams, Claudia J. de Dood, Elisa M. Tjon Kon Fat, Paul L. A. M. Corstjens

Author Affiliations +

Proceedings Volume 8947, Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XII; 89470P (2014) https://doi.org/10.1117/12.2036906
Event: SPIE BiOS, 2014, San Francisco, California, United States

Abstract

Point-of-care (POC) testing is increasingly applied as a cost effective alternative to many diagnostic tests. Key in POC testing is to create sufficient assay sensitivity with relatively low cost reagents and equipment. For this purpose we have employed a unique reporter, upconverting phosphor (UCP) particles, in combination with lateral flow (LF) assays. UCPs, submicron ceramic particles doped with rare earth ions (lanthanides), convert infrared to visible light and do not suffer from autofluorescence which limits conventional fluorescence based assays. Low cost handheld readers and microfluidics were evaluated in various applications. Designed assays are well suited for applications outside diagnostic laboratories, in resource poor settings, and can even be used by patients at home. Using two distinctly different UCP-LF assay formats, we focussed on assays for infectious diseases based on the detection of pathogen-specific antibodies and/or antigens including nucleic acids to demonstrate active infection with HIV. Only minor adaptation of the standard UCP-LF assay format is needed to render the format suitable for applications involving low affinity capture antibodies (e.g. in the detection of neurotoxin, botulism), capture of small molecules (e.g. detection of melatonin, a key hormone in chronopharmacology) or the use of dry UCP reagents (e.g. detection of protein based fruit-ripening markers, of economic interest in agriculture). Finally, we anticipate on developments in healthcare (personalized medicine) by discussing the potential of one of the UCP-LF assay formats to measure serum trough levels of immunodrugs (e.g. infliximab or adalimumab) in patients treated for inflammatory bowel disease and rheumatoid arthritis.

Citation Download Citation

Hans J. Tanke, Michel Zuiderwijk, Karien C. Wiesmeijer, Robert N. Breedveld, William R. Abrams, Claudia J. de Dood, Elisa M. Tjon Kon Fat, and Paul L. A. M. Corstjens "The use of upconverting phosphors in point-of-care (POC) testing", Proc. SPIE 8947, Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XII, 89470P (4 March 2014); https://doi.org/10.1117/12.2036906

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available